Gene · 4734
Papers3,453
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,453
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TMX1 promotes the progression of hepatocellular carcinoma by inhibiting ferroptosis via stabilizing FABP5. | Cell Signal | 2026 | 41482143 | PubTator, text mining | PubMed |
| Nanoparticle-Hydrogel Sustained-Release System for the Delivery of si-NEDD4: A Promising Strategy for the Treatment of Keloids. | ACS Biomater Sci Eng | 2026 | 41472645 | PubTator, text mining | PubMed |
| PIPKI-PIP2 promotes cell migration by recruiting Smurf1 to the membrane and increasing its activity. | Acta Biochim Biophys Sin (Shanghai) | 2026 | 41466454 | PubTator, text mining | PubMed |
| The Multifaceted Role of p53 in Musculoskeletal Diseases: A Comprehensive Review. | Int J Rheum Dis | 2026 | 41454461 | PubTator, text mining | PubMed |
| SEMA5B depletion suppresses cell proliferation and glycolysis by downregulating VDAC2 expression in esophageal squamous cell carcinoma. | Int J Biol Macromol | 2026 | 41407227 | PubTator, text mining | PubMed |
| HDAC5 deficiency induces intrinsic resistance to KRAS inhibition by disrupting c-Myc acetylation-ubiquitination homeostasis. | J Clin Invest | 2026 | 41379561 | PubTator, text mining | PubMed |
| NEDD 4 Pyre-fighters to extinguish inflammation: NEDD4L ubiquitinates Gasdermin D and Gasdermin E to dampen pyroptosis. | Cell Death Differ | 2026 | 41366095 | PubTator, text mining | PubMed |
| LAMA4, regulated by the transcription factor SP1 or the ubiquitin ligase NEDD4, mediates HUVEC dysfunction under hypoxia/reoxygenation conditions. | Cytotechnology | 2026 | 41280659 | PubTator, text mining | PubMed |
| NEDD4 regulates VEGF signaling and mTOR to promote angiogenesis and the cell cycle in steroid‑induced osteonecrosis of the femoral head. | Mol Med Rep | 2026 | 41268613 | PubTator, text mining | PubMed |
| RETRACTION: PUM2 Promoted Osteoarthritis Progression Through PTEN-Mediated Chondrocyte Ferroptosis by Facilitating NEDD4 mRNA Degradation. | Environ Toxicol | 2026 | 41255040 | PubTator, text mining | PubMed |
| A novel lncRNA, lncMCL1, modulates neural pyroptosis associated with epilepsy via stabilizing DDX3X. | Cell Death Differ | 2026 | 40983632 | PubTator, text mining | PubMed |
| Ubiquitination of Metabotropic Glutamate Receptors and Associated Synaptic Proteins In Vitro and In Vivo. | J Cell Signal | 2025 | 41847598 | PubTator, text mining | PubMed |
| Ubiquitin signatures on aggregating proteins in neurodegeneration. | Essays Biochem | 2025 | 41837791 | PubTator, text mining | PubMed |
| The PI3K/AKT/mTOR pathway in scar remodeling and keloid formation: mechanisms and therapeutic perspectives. | Front Pharmacol | 2025 | 41424791 | PubTator, text mining | PubMed |
| Metabolic enzyme PFKFB3 mediates matrix stiffness-potentiated tumour growth and radiotherapeutic resistance in HCC. | Clin Transl Med | 2025 | 41292194 | PubTator, text mining | PubMed |
| Poly-ubiquitylated transmembrane proteins outcompete other cargo for limited space inside clathrin-coated vesicles. | Cell Rep | 2025 | 41201087 | PubTator, text mining | PubMed |
| Mammalian and bacterial adaptors function as co-disinhibitory pairs to activate the E3 ubiquitin ligase WWP2. | J Biol Chem | 2025 | 41135677 | PubTator, text mining | PubMed |
| Extracellular vesicles: cargo loading, degradation and secretory pathways, and their intersection with autophagy. | Extracell Vesicles Circ Nucl Acids | 2025 | 41132500 | PubTator, text mining | PubMed |
| Inhibiting NEDD4 in triple-negative breast cancer cells reprograms tumor immune microenvironment via the β-TrCP/YAP/ECM axis. | Cell Rep Med | 2025 | 41125065 | PubTator, text mining | PubMed |
| Scientometric analysis of extracellular vesicles in vision science (up to 2024). | J Nanobiotechnology | 2025 | 41074034 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4734/papers?page=4